Healthcare & Life Sciences Private Equity Deal Tracker: Daktari Diagnostics Secures $15.5 Million in Financing

McGuireWoods LLP
Contact

Daktari Diagnostics has announced it has closed a $15.5 million series D round of funding.

Daktari, headquartered in Cambridge, Mass., is a developer of portable diagnostic products.

The funding round was led by new investors Eastern Capital Limited and the Merck Global Health Innovation Fund. Existing investors Norwich Ventures and Partners Innovation Fund also participated.

Daktari’s CEO indicated the company’s near-term goal is to create a menu of tests for major infectious diseases that can run on the Daktari CD4 diagnostic platform in 15-30 minutes.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations. Attorney Advertising.

© McGuireWoods LLP

Written by:

McGuireWoods LLP
Contact
more
less

PUBLISH YOUR CONTENT ON JD SUPRA NOW

  • Increased visibility
  • Actionable analytics
  • Ongoing guidance

McGuireWoods LLP on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide